HUM Humana PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: HUM
- PE Ratio
The PE ratio for Humana stock stands at 19.12 as of Jul 31, 2025. The calculation is based on the latest EPS of $13.07 and the stock price of $249.87 per share. A decrease of 15% has been observed in the PE ratio compared to its average of 22.6 of the last four quarters.
HUM PE ratio history
Over the last ten years, the average PE ratio of Humana has been 21.22. The current 19.12 P/E ratio is 10% lower than the historical average. Looking back at the last ten years, HUM's PE ratio peaked in the Dec 2016 quarter at 49.64, with a price of $204.03 and an EPS of $4.11. The Sep 2020 quarter marked the lowest point at 13.17, with a price of $413.89 and an EPS of $31.42.
Humana PE ratio by year
Maximum annual increase: 137.51% in 2016
Maximum annual decrease: -70.51% in 2017
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 25.35 | 11.23% | $253.71 | $10.01 |
| 2023 | 22.79 | -1.21% | $457.81 | $20.09 |
| 2022 | 23.07 | 13.37% | $512.19 | $22.2 |
| 2021 | 20.35 | 26.32% | $463.86 | $22.79 |
| 2020 | 16.11 | -11.19% | $410.27 | $25.47 |
| 2019 | 18.14 | -22.51% | $366.52 | $20.2 |
| 2018 | 23.41 | 59.9% | $286.48 | $12.24 |
| 2017 | 14.64 | -70.51% | $248.07 | $16.94 |
| 2016 | 49.64 | 137.51% | $204.03 | $4.11 |
| 2015 | 20.9 | 8.23% | $178.51 | $8.54 |
| 2014 | 19.31 | 46.07% | $143.63 | $7.44 |
| 2013 | 13.22 | 45.59% | $103.22 | $7.81 |
| 2012 | 9.08 | -11.07% | $68.63 | $7.56 |
| 2011 | 10.21 | 22.13% | $87.61 | $8.58 |
| 2010 | 8.36 | 18.25% | $54.74 | $6.55 |
Humana PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2025 | 18.71 | 0.27% | $244.48 | $13.07 |
| Mar 2025 | 18.66 | -26.39% | $264.6 | $14.18 |
| Dec 2024 | 25.35 | -8.19% | $253.71 | $10.01 |
| Sep 2024 | 27.61 | 5.06% | $316.74 | $11.47 |
| Jun 2024 | 26.28 | 23.5% | $373.65 | $14.22 |
| Mar 2024 | 21.28 | -6.63% | $346.72 | $16.29 |
| Dec 2023 | 22.79 | 13.72% | $457.81 | $20.09 |
| Sep 2023 | 20.04 | 20.94% | $486.52 | $24.28 |
| Jun 2023 | 16.57 | -15.37% | $447.13 | $26.99 |
| Mar 2023 | 19.58 | -15.13% | $485.46 | $24.79 |
| Dec 2022 | 23.07 | 5.39% | $512.19 | $22.2 |
| Sep 2022 | 21.89 | 15.15% | $485.19 | $22.16 |
| Jun 2022 | 19.01 | 3.48% | $468.07 | $24.62 |
| Mar 2022 | 18.37 | -9.73% | $435.17 | $23.69 |
| Dec 2021 | 20.35 | 9% | $463.86 | $22.79 |
HUM Price vs fair value
HUM average PE ratio chart
HUM's current PE ratio is lower than its 3, 5 and 10-year averages.
HUM PE vs peers
HUM's PE ratio stands higher than its peer stocks UNH and CI. Humana's current PE ratio of 19.12 is higher than the average of its peers, which is 9.79.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CNC Centene Corp | 6.29 | $12.73B |
| MOH Molina Healthcare Inc | 7.62 | $8.41B |
| UNH Unitedhealth Group Inc | 9.88 | $215.69B |
| CI Cigna Corp | 14.44 | $70.05B |
| HUM Humana Inc | 18.92 | $29.74B |
Frequently asked questions
What is Humana's PE ratio?
HUM's price to earnings ratio is 19.12 as of Jul 31, 2025.
What is the 3-year average PE ratio for Humana (HUM)?
Over the last 3 years, the average price to earnings ratio for HUM stock is 21.82.
What is the 5-year average PE ratio for Humana (HUM)?
Over the last 5 years, the average price to earnings ratio for HUM stock is 20.28.
What is the highest PE ratio for HUM?
Over the last ten years, the Dec 2016 quarter recorded the highest quarterly PE ratio at 49.64.
How does the current PE ratio for HUM compare to its historical average?
HUM's current price to earnings ratio is 10% below its 10-year historical average.
How is HUM's PE ratio calculated (Humana PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jul 31, 2025), Humana's share price is $249.87. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2025 is $13.07. Therefore, Humana's PE ratio for today is 19.12. PE RATIO(19.12) = STOCK PRICE($249.87) / TTM EPS($13.07)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.